1. Home
  2. CYTK vs TTC Comparison

CYTK vs TTC Comparison

Compare CYTK & TTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$72.72

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Toro Company (The)

TTC

Toro Company (The)

N/A

Current Price

$93.33

Market Cap

8.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
TTC
Founded
1997
1914
Country
United States
United States
Employees
N/A
9227
Industry
Biotechnology: Pharmaceutical Preparations
Tools/Hardware
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
8.8B
IPO Year
2004
1994

Fundamental Metrics

Financial Performance
Metric
CYTK
TTC
Price
$72.72
$93.33
Analyst Decision
Strong Buy
Buy
Analyst Count
19
4
Target Price
$89.26
$104.00
AVG Volume (30 Days)
1.8M
593.5K
Earning Date
05-05-2026
06-04-2026
Dividend Yield
N/A
1.66%
EPS Growth
N/A
N/A
EPS
N/A
2.99
Revenue
$13,368,000.00
$2,618,650,000.00
Revenue This Year
$7.37
$6.13
Revenue Next Year
$310.19
$4.45
P/E Ratio
N/A
$42.20
Revenue Growth
N/A
4.53
52 Week Low
$47.22
$67.64
52 Week High
$88.31
$105.19

Technical Indicators

Market Signals
Indicator
CYTK
TTC
Relative Strength Index (RSI) 42.80 35.52
Support Level $73.34 $91.43
Resistance Level $79.73 $93.82
Average True Range (ATR) 2.22 2.57
MACD -0.38 -0.59
Stochastic Oscillator 39.09 8.13

Price Performance

Historical Comparison
CYTK
TTC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

Share on Social Networks: